Liraglutide
- Product NDC
- 71288-563
- 11-digit product format
- 712880563
- Labeler code
- 71288
- Product ID
- 71288-563_c4f6adef-1b2a-4e7c-b7a9-b19d4ed1df36
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- liraglutide
- Dosage form
- INJECTION
- Route
- SUBCUTANEOUS
- Labeler
- Meitheal Pharmaceuticals Inc.
- Application
- ANDA218115
- Marketing category
- ANDA
- Marketing start
- 2025-04-02
- Substance
- LIRAGLUTIDE
- Active strength
- 6 mg/mL
- Pharmacologic classes
- GLP-1 Receptor Agonist [EPC], Glucagon-Like Peptide 1 [CS], Glucagon-like Peptide-1 (GLP-1) Agonists [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2027-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Liraglutide
- Listing expiration
- 2027-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| LIRAGLUTIDE | 6 mg/mL |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | 839I73S42A |
| Rxcui | 897122 |
DailyMed Product Concepts#
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 71288-563 | LIRAGLUTIDE INJECTION [MEITHEAL PHARMACEUTICALS INC.] | 7 | Current NDC | 20250406_0efc3a89-211a-4496-baab-e8265e07de2b.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Sample | Exclude flag | Status |
|---|
| 71288-563-84 | 71288056384 | 3 SYRINGE, PLASTIC in 1 CARTON (71288-563-84) / 3 mL in 1 SYRINGE, PLASTIC | 2025-04-02 | No | No | Historical |
| 71288-563-85 | 71288056385 | 2 SYRINGE, PLASTIC in 1 CARTON (71288-563-85) / 3 mL in 1 SYRINGE, PLASTIC | 2025-04-02 | No | No | Historical |